Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Dental Pulp Stem Cells in Chronic Periodontitis
NCT04983225Phase 1Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2021
- Primary completion
- Jul 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of human dental pulp mesenchymal stem cell injection in chronic periodontitis (6 arms), sponsored by Peking University Third Hospital. Primary endpoints: Changes from baseline in respiration rate of Vital Signs at 180 days, Changes from baseline in heart rate of Vital Signs at 180 days and 12 more. Status: unknown.
02
Drugs
human dental pulp mesenchymal stem cell injection
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT04983225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04983225.